Menopause: Questions and Answers for Improving Homeopathic Clinical Practice

Abstract

Background Medical attention for menopausal women is frequently delivered by health care providers (general practitioners, gynecologists or homeopathic physicians) who are not specialized in post-reproductive care. Homeopathy has been used for treating menopausal complaints for more than two centuries. Therefore, it is important to improve clinical knowledge in this field among homeopathic physicians. Nowadays, there is a special interest in the study of menopause-related chronic conditions due to the impact on women's quality of life. The aim of this review is to address the important key points of the menopause, clinical assessment, and available tests for evaluating menopausal women, as well as some general topics regarding homeopathic clinical practice for menopause.

Methods and Results A literature search regarding menopause and current guidelines and recommendations was performed. To be practical and concise, the information is presented in the form of questions and answers. Currently, there is an international classification of woman's reproductive aging that can be useful for clinical and research purposes in homeopathy. A comprehensive homeopathic approach is mandatory for evaluating women with a healthy menopause, but also for those experiencing co-morbidities. In an integrative health care system, several assessment resources can be incorporated into the homeopathic consultations. Clinical and laboratory examinations for detecting metabolic disorders (dyslipidemia, insulin resistance, diabetes and hypertension, among others), mood disorders, cognitive impairment and osteoporosis are available in many clinical settings. Screening for gynecological cancers is an international recommendation at this stage. All data obtained from homeopathic consultations would help to integrate well-documented case reports. This would give the possibility to generate hypotheses to design high-quality clinical research.

Conclusion Improving homeopathic clinical practice for menopause is useful for both clinical and research purposes. The international recommendations for evaluating menopausal women should be incorporated in homeopathic clinical practice, mainly in clinical settings where homeopathy is integrated in outpatient services.

Keywords

homeopathic clinical practice - healthy menopause - transition to menopause - post menopause - homeopathic practitioners - homeopathic physicians

Publication History

Received: 20 March 2022

Accepted: 10 June 2022

Article published online:
22 November 2022

• References

• 1 Doubova SV, Espinosa-Alarcón P, Flores-Hernández S, Infante C, Pérez-Cuevas R. Integrative health care model for climacteric stage women: design of the intervention. BMC Womens Health 2011; 11: 6
• 2 Langer RD, Hodis HN, Lobo RA, Allison MA. Hormone replacement therapy—where are we now?. Climacteric 2021; 24: 3-10
• 3 Guernsey HN. The Application of the Principles and Practice of Homeopathy to Obstetrics and the Disorders Peculiar to Women and Young Children. Calcutta, India: Set, Dey & Co; 1866
• 4 Djapardy V, Panay N. Alternative and non-hormonal treatments to symptoms of menopause. Best Pract Res Clin Obstet Gynaecol 2022; 81: 45-60
• 5 Buhling KJ, Daniels BV, Studnitz FS, Eulenburg C, Mueck AO. The use of complementary and alternative medicine by women transitioning through menopause in Germany: results of a survey of women aged 45-60 years. Complement Ther Med 2014; 22: 94-98
• 6 Samuels N, Freed Y, Weitzen R. et al. Feasibility of homeopathic treatment for symptom reduction in an integrative oncology service. Integr Cancer Ther 2018; 17: 486-492
• 7 Ruiz-Mandujano ME, García-Vivas J, Luna-Reséndiz R, Ochoa-Bernal F, Sánchez-Monroy V. Evaluación del tratamiento homeopático de mujeres en climaterio entre los 45 y 60 años con la Menopause Rating Scale (MRS). La Homeopatía de México 2019; 88: 28-35
• 8 Gupta J, Kulshreshtha D, Lamba CD. et al. Homoeopathic medicine–Sepia for the management of menopausal symptoms: a multicentric, randomised, double-blind placebo-controlled clinical trial. Indian Journal of Research in Homoeopathy 2019; 13: 219-228
• 9 Stute P, Ceausu I, Depypere H. et al. A model of care for healthy menopause and ageing: EMAS position statement. Maturitas 2016; 92: 1-6
• 10 Macías-Cortés E. Menopause is more than hot flashes: what is missing in homeopathic research? A narrative review. Homeopathy 2022; 111: 79-96
• 11 Teut M, van Haselen RA, Rutten L, Lamba CD, Bleul G, Ulbrich-Zürni S. Case reporting in homeopathy—an overview of guidelines and scientific tools. Homeopathy 2022; 111: 2-9
• 12 Davis SR, Lambrinoudaki I, Lumsden M. et al. Menopause. Nat Rev Dis Primers 2015; 1: 15004
• 13 Wise PM. Neuroendocrine modulation of the “menopause”: insights into the aging brain. Am J Physiol 1999; 277: E965-E970
• 14 Butler L, Santoro N. The reproductive endocrinology of the menopausal transition. Steroids 2011; 76: 627-635
• 15 Harlow SD, Gass M, Hall JE. et al; for the STRAW+10 Collaborative Group. Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause 2012; 19: 387-395
• 16 Hernández-Valencia M, Córdova-Pérez N, Basurto L. et al. Frequency of symptoms of the climacteric syndrome. Ginecol Obstet Mex 2010; 78: 232-237
• 17 Santoro N, Roeca C, Peters BA, Neal-Perry G. The menopause transition: signs, symptoms, and management options. J Clin Endocrinol Metab 2021; 106: 1-15
• 18 Col NF, Guthrie JR, Politi M, Dennerstein L. Duration of vasomotor symptoms in middle-aged women: a longitudinal study. Menopause 2009; 16: 453-457
• 19 Politi MC, Schleinitz MD, Col NF. Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis. J Gen Intern Med 2008; 23: 1507-1513
• 20 Roush K. Managing menopausal symptoms. Am J Nurs 2012; 112: 28-35
• 21 Bromberger JT, Kravitz HM, Chang YF, Cyranowski JM, Brown C, Matthews KA. Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN). Psychol Med 2011; 41: 1879-1888
• 22 Soares CN. Depression in peri- and postmenopausal women: prevalence, pathophysiology and pharmacological management. Drugs Aging 2013; 30: 677-685
• 23 Harlow BL, Cohen LS, Otto MW, Spiegelman D, Cramer DW. Prevalence and predictors of depressive symptoms in older premenopausal women: the Harvard Study of Moods and Cycles. Arch Gen Psychiatry 1999; 56: 418-424
• 24 Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, Meyer PM. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 2003; 10: 19-28
• 25 Freeman EW, Sammel MD, Gross SA, Pien GW. Poor sleep in relation to natural menopause: a population-based 14-year follow-up of midlife women. Menopause 2015; 22: 719-726
• 26 Sands-Lincoln M, Loucks EB, Lu B. et al. Sleep duration, insomnia, and coronary heart disease among postmenopausal women in the Women's Health Initiative. J Womens Health (Larchmt) 2013; 22: 477-486
• 27 Knutson KL, Spiegel K, Penev P, Van Cauter E. The metabolic consequences of sleep deprivation. Sleep Med Rev 2007; 11: 163-178
• 28 Karlamangla AS, Lachman ME, Han W, Huang M, Greendale GA. Evidence for cognitive aging in midlife women: study of women's health across the nation. PLoS One 2017; 12: e0169008
• 29 Haring B, Leng X, Robinson J. et al. Cardiovascular disease and cognitive decline in postmenopausal women: results from the Women's Health Initiative Memory Study. J Am Heart Assoc 2013; 2: e000369
• 30 Lim AS, Kowgier M, Yu L, Buchman AS, Bennett DA. Sleep fragmentation and the risk of incident Alzheimer's disease and cognitive decline in older persons. Sleep (Basel) 2013; 36: 1027-1032
• 31 Portman DJ, Gass ML. Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Menopause 2014; 21: 1063-1068
• 32 Levine KB, Williams RE, Hartmann KE. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause 2008; 15: 661-666
• 33 Leiblum SR, Koochaki PE, Rodenberg CA, Barton IP, Rosen RC. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause 2006; 13: 46-56
• 34 Davis SR, Moreau M, Kroll R. et al; APHRODITE Study Team. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 2008; 359: 2005-2017
• 35 van Dijk GM, Kavousi M, Troup J, Franco OH. Health issues for menopausal women: the top 11 conditions have common solutions. Maturitas 2015; 80: 24-30
• 36 Lima R, Wofford M, Reckelhoff JF. Hypertension in postmenopausal women. Curr Hypertens Rep 2012; 14: 254-260
• 37 Stevenson JC. A woman's journey through the reproductive, transitional and postmenopausal periods of life: impact on cardiovascular and musculo-skeletal risk and the role of estrogen replacement. Maturitas 2011; 70: 197-205
• 38 Chomistek AK, Manson JE, Stefanick ML. et al. Relationship of sedentary behavior and physical activity to incident cardiovascular disease: results from the Women's Health Initiative. J Am Coll Cardiol 2013; 61: 2346-2354
• 39 Gast GC, Grobbee DE, Pop VJ. et al. Menopausal complaints are associated with cardiovascular risk factors. Hypertension 2008; 51: 1492-1498
• 40 Neogi T, Zhang Y. Epidemiology of osteoarthritis. Rheum Dis Clin North Am 2013; 39: 1-19
• 41 Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 2006; 194: S3-S11
• 42 Sowers M, Crutchfield M, Bandekar R. et al. Bone mineral density and its change in pre-and perimenopausal white women: the Michigan Bone Health Study. J Bone Miner Res 1998; 13: 1134-1140
• 43 Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003; 88: 2404-2411
• 44 Khoo CL, Perera M. Diabetes and the menopause. J Br Menopause Soc 2005; 11: 6-11
• 45 Gold EB. The timing of the age at which natural menopause occurs. Obstet Gynecol Clin North Am 2011; 38: 425-440
• 46 Ferlay J, Soerjomataram I, Dikshit R. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-E386
• 47 Carpenter JS, Rand KL. Modeling the hot flash experience in breast cancer survivors. Menopause 2008; 15: 469-475
• 48 Kotsopoulos J. Menopausal hormones: definitive evidence for breast cancer. Lancet 2019; 394: 1116-1118
• 49 Gudmundsson LS, Scher AI, Aspelund T. et al. Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study. BMJ 2010; 341: c3966
• 50 Frediani F, Villani V. Migraine and depression. Neurol Sci 2007; 28: S161-S165
• 51 The North American Menopause Society. Clinical Evaluation and Counseling. Accessed February 14, 2022: https://www.menopause.org/publications/clinical-care-recommendations/chapter-5-clinical-evaluation-and-counseling
• 52 Bickley LS. Bates Guía de Exploración física e historia clínica. 13ª Ed. México: Editorial Wolters Kluwer; 2021
• 53 National Institute for Health and Care Excellence. Menopause: diagnosis and management. Published 12 November 2015. Last updated 5 December 2019. Accessed February 19, 2022 at: https://www.nice.org.uk/guidance/ng23/chapter/Recommendations#individualised-care
• 54 Sourouni M, Zangger M, Honermann L, Foth D, Stute P. Assessment of the climacteric syndrome: a narrative review. Arch Gynecol Obstet 2021; 304: 855-862
• 55 Goldstein S. An efficient tool for the primary care management of menopause. Can Fam Physician 2017; 63: 295-298
• 56 Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-296
• 57 Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988; 8: 77-100
• 58 Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1997; 1: 385-401
• 59 Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389
• 60 Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 50-55
• 61 Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press Inc., ; Palo Alto, CA: 1983
• 62 Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol 1992; 31: 301-306
• 63 Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988; 56: 893-897
• 64 Mension E, Alonso I, Tortajada M. et al. Genitourinary Syndrome of Menopause Assessment Tools. J Midlife Health 2021; 12: 99-102
• 65 Hsu HC, Lin MH, Shih WM, Tsao LI. Examining the psychometric properties of the brief ‘Menopausal Symptoms Distress Affecting Sleep Quality Scale’. J Clin Nurs 2015; 24: 3654-3663
• 66 Zagalaz-Anula N, Hita-Contreras F, Martínez-Amat A, Cruz-Díaz D, Lomas-Vega R. Psychometric properties of the medical outcomes study sleep scale in Spanish postmenopausal women. Menopause 2017; 24: 824-831
• 67 Buysse DJ, Reynolds III CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213
• 68 D'Agostino Sr RB, Vasan RS, Pencina MJ. et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117: 743-753
• 69 Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007; 297: 611-619
• 70 American College of Cardiology.. ASCVD risk estimator plus. Accessed February 24, 2022 at: https://tools.acc.org/ASCVD-Risk-Estimator-Plus/#!/calculate/estimate/
• 71 American College of Cardiology. ASCVD Risk Estimator Plus. Accessed February 24, 2022 at: https://www.cvriskcalculator.com/
• 72 Heinemann K, Ruebig A, Potthoff P. et al. The Menopause Rating Scale (MRS) scale: a methodological review. Health Qual Life Outcomes 2004; 2: 45
• 73 Delaplaine RW, Bottomy JR, Blatt M, Wiesbader H, Kupperman HS. Effective control of the surgical menopause by estradiol pellet implantation at the time of surgery. Surg Gynecol Obstet 1952; 94: 323-333
• 74 Alder E. The Blatt-Kupperman menopausal index: a critique. Maturitas 1998; 29: 19-24
• 75 Hilditch JR, Lewis J, Peter A. et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 1996; 24: 161-175
• 76 Lewis JE, Hilditch JR, Wong CJ. Further psychometric property development of the Menopause-Specific Quality of Life questionnaire and development of a modified version, MENQOL-Intervention questionnaire. Maturitas 2005; 50: 209-221
• 77 Greene JG. Constructing a standard climacteric scale. Maturitas 2008; 61: 78-84
• 78 Bordet MF, Colas A, Marijnen P, Masson J, Trichard M. Treating hot flushes in menopausal women with homeopathic treatment – results of an observational study. Homeopathy 2008; 97: 10-15
• 79 Andrade DCDS, Carmona F, Angelucci MA, Martinez EZ, Pereira AMS. Efficacy of a homeopathic medicine of Capsicum frutescens L. (Solanaceae) in the treatment of hot flashes in menopausal women: a phase-2 randomized controlled trial. Homeopathy 2019; 108: 102-107
• 80 Jacobs J, Herman P, Heron K, Olsen S, Vaughters L. Homeopathy for menopausal symptoms in breast cancer survivors: a preliminary randomized controlled trial. J Altern Complement Med 2005; 11: 21-27
• 81 Heudel PE, Van Praagh-Doreau I, Duvert B. et al. Does a homeopathic medicine reduce hot flushes induced by adjuvant endocrine therapy in localized breast cancer patients? A multicenter randomized placebo-controlled phase III trial. Support Care Cancer 2019; 27: 1879-1889
• 82 Thompson EA, Montgomery A, Douglas D, Reilly D. A pilot, randomized, double-blinded, placebo-controlled trial of individualized homeopathy for symptoms of estrogen withdrawal in breast-cancer survivors. J Altern Complement Med 2005; 11: 13-20
• 83 Nayak C, Singh V, Singh K. et al. Management of distress during climacteric years by homeopathic therapy. J Altern Complement Med 2011; 17: 1037-1042
• 84 Teut M, Lüdtke R, Schnabel K, Willich SN, Witt CM. Homeopathic treatment of elderly patients—a prospective observational study with follow-up over a two year period. BMC Geriatr 2010; 10: 10
• 85 Spence DS, Thompson EA, Barron SJ. Homeopathic treatment for chronic disease: a 6-year, university-hospital outpatient observational study. J Altern Complement Med 2005; 11: 793-798
• 86 Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet 2019; 394: 1159-1168
• 87 Hahnemann S. . Organon of Medicine, sixth ed., B Jain Publishers PVt Ltd, 1900, pp 224.
• 88 Michieli R, Musto M. Bone health in menopausal women: a role for General Practitioners. Clin Cases Miner Bone Metab 2017; 14: 71-73
• 89 Berk M, Sarris J, Coulson CE, Jacka FN. Lifestyle management of unipolar depression. Acta Psychiatr Scand Suppl 2013; 38-54
• 90 American Sleep Association. Sleep hygiene. Accessed February 25, 2022 at: https://www.sleepassociation.org/about-sleep/sleep-hygiene-tips/sleep-hygiene/
• 91 Pérez-Jiménez F, Pascual V, Meco JF. et al. Document of recommendations of the SEA 2018. Lifestyle in cardiovascular prevention. Clin Investig Arterioscler 2018; 30: 280-310